Search
  • Within this site
AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Back to search results

Arysulfanyl Pyrazolone to Block SOD1 Aggregation for the Treatment of Amyotrophic Lateral Sclerosis


Technology Benefits

Proof-of-concept in ALS mouse models. Initial proof-of concept in other cell lines and additional animal modelsNorthwestern University’s unique strength in battling ALS lies in having dedicated researchers, including Teepu Siddique (Feinberg), who spearheaded the creation of a “research standard” model system for ALS.


Detailed Technology Description

Three series of New Chemical Entities (NCEs) that exhibited efficacy in an ALS animal model were identified and are potentially useful for the treatment of ALS and other motor neuron diseases. #Therapeutic #CNS #small molecule #ALS # Lou Gehrig's disease #motor neuron disease


Country/Region

USA

For more information, please click Here
Business of IP Asia Forum
Desktop View